drugset / Trial / NCT03916978

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

NCT03916978 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

Timeline

Start
2019-05-21
Primary completion
2027-01-30
Completion
2028-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Unknown — Other